Northcape Wealth Management’s Novartis NVS Stock Holding History

Northcape Wealth Management’s Portfolio NVS Stock Details NVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.28M	Hold	8,370	–	–	0.35%	66
2025 Q4	$1.15M	Hold	8,370	–	–	0.33%	70
2025 Q3	$1.07M	Hold	8,370	–	–	0.31%	71
2025 Q2	$1.01M	Hold	8,370	–	–	0.31%	69
2025 Q1	$933K	Sell	8,370 -200	-2%	-$21.3K	0.3%	69
2024 Q4	$834K	Hold	8,570	–	–	0.27%	73
2024 Q3	$986K	Hold	8,570	–	–	0.32%	69
2024 Q2	$912K	Buy	8,570 +998	+13%	+$100K	0.33%	70
2024 Q1	$732K	Sell	7,572 -1,690	-18%	-$173K	0.27%	77
2023 Q4	$935K	Sell	9,262 -94	-1%	-$9.07K	0.34%	71
2023 Q3	$953K	Sell	9,356 -496	-5%	-$50.3K	0.37%	71
2023 Q2	$994K	Sell	9,852 -127	-1%	-$12.7K	0.36%	70
2023 Q1	$918K	Buy	+9,979	New	+$872K	0.33%	73
2022 Q4	–	Sell	-11,605	Closed	-$882K	–	117
2022 Q3	$882K	Buy	11,605 +3,233	+39%	+$268K	0.31%	74
2022 Q2	$708K	Sell	8,372 -3,271	-28%	-$287K	0.27%	71
2022 Q1	$1.02M	Buy	11,643 +3,271	+39%	+$283K	0.3%	77
2021 Q4	$732K	Buy	+8,372	New	+$695K	0.25%	71

Other funds holding NVS

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Northcape Wealth Management's NVS Position: Q1 2026 in Review

Northcape Wealth Management held its Novartis (NVS) position steady in Q1 2026 at 8,370 shares worth $1.28M. The position accounts for 0.35% of the portfolio, ranked #66.

Northcape Wealth Management first reported a position in NVS in Q4 2021 and has held it in 17 quarters since. 1,590 funds tracked by Wall St. Rank hold NVS as of Q1 2026.

Northcape Wealth Management held 8,370 shares of Novartis worth $1.28M as of Q1 2026.
Northcape Wealth Management left its Novartis share count unchanged in Q1 2026.
Novartis made up 0.35% of Northcape Wealth Management's portfolio in Q1 2026, its #66 holding.
Northcape Wealth Management first reported a position in Novartis in Q4 2021 and has held it in 17 quarters since.
1,590 funds tracked by Wall St. Rank held Novartis as of Q1 2026.

Based on Northcape Wealth Management's 13F filing for Q1 2026, filed 1 May 2026.